NOT.DU NOVARTIS N

Other Metals & Mining Dusseldorf Exchange
- EUR
Market cap
-
P/E
-
P/B
8.19x
ROE
27.3%
Dividend yield
4.87%
Fundamental score
2.9/5

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NOT.DU undervalued?

Graham number

The Graham number of NOVARTIS N cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NOVARTIS N fundamental analysis

13 of 22 checks passed

ROE 2/2

High return on equity (27.3%), above 20%.

ROA 1/1

Return on assets (8.7%) is above the industry median (3.8%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (21.2%) is above the 5-year average (15.4% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (21.2%) is above the industry median (7.9%).

Revenue Growth 1/2

Revenue grew 9.3% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (98.6%), up to 100%.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 8.4x against interest expense, well covered.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (8.2x) is above the industry median (2.0x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield cannot be calculated.

Dividend Stability 2/2

Dividends paid without a cut of more than 10% for 10 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 55.9%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

NOVARTIS N stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NOVARTIS N

There is no Profile data available for NOT.DU.

Full company profile